Skip to main content
Top
Published in: Gastric Cancer 2/2016

01-04-2016 | Original Article

Clinicopathological features of gastric cancer in young patients

Authors: Yukiko Takatsu, Naoki Hiki, Souya Nunobe, Manabu Ohashi, Michitaka Honda, Toshiharu Yamaguchi, Toshifusa Nakajima, Takeshi Sano

Published in: Gastric Cancer | Issue 2/2016

Login to get access

Abstract

Background

Early-onset gastric cancer is relatively rare. To evaluate the clinicopathological features and surgical outcome of young patients with gastric cancer, this retrospective comparative study was conducted.

Methods

From 2000 to 2010, 4882 patients underwent surgery for gastric adenocarcinoma in our institution. A total of 136 patients under 40 years old were enrolled as the young group, and a total of 1435 patients aged between 60 and 69 were identified as the control group for this study. The patient’s characteristics, pathological findings, surgical and clinical outcomes were reviewed, and the risk factors of recurrence were compared between the two groups.

Results

Among the young group, patients had significantly fewer comorbidities and postoperative complications. The patient proportion having 7 or more lymph node metastases was higher in the young group (25 %) than in the control group (16 %). The presence of lymph node metastasis was identified as a strong risk factor for recurrence (odds ratio = 4.31) in the young group according to the results of the step-wise logistic regression analysis. Although the disease-specific survival at stage II was relatively better in the young group (p = 0.0439) than in the control group, there were no significant differences in overall survival for all stages.

Conclusion

Early-onset gastric cancer is likely to present lymph node metastases. The survival rate of gastric cancer in young patients was equivalent to that in patients in their 60s, which is the typical age at onset.
Literature
1.
go back to reference Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg. 1996;172:473–6; discussion 6–7. Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg. 1996;172:473–6; discussion 6–7.
2.
go back to reference Nakamura R, Saikawa Y, Takahashi T, Takeuchi H, Asanuma H, Yamada Y, et al. Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol. 2011;16:328–34.CrossRefPubMed Nakamura R, Saikawa Y, Takahashi T, Takeuchi H, Asanuma H, Yamada Y, et al. Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol. 2011;16:328–34.CrossRefPubMed
3.
go back to reference Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg. 2009;144:506–10.CrossRefPubMed Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg. 2009;144:506–10.CrossRefPubMed
4.
go back to reference Saito H, Takaya S, Fukumoto Y, Osaki T, Tatebe S, Ikeguchi M. Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Medica. 2012;55:57–61.PubMedPubMedCentral Saito H, Takaya S, Fukumoto Y, Osaki T, Tatebe S, Ikeguchi M. Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Medica. 2012;55:57–61.PubMedPubMedCentral
5.
go back to reference Dhobi MA, Wani KA, Parray FQ, Wani RA, Wani ML, Peer GQ, et al. Gastric cancer in young patients. Int J Clin Oncol. 2013;2013:981654. Dhobi MA, Wani KA, Parray FQ, Wani RA, Wani ML, Peer GQ, et al. Gastric cancer in young patients. Int J Clin Oncol. 2013;2013:981654.
6.
go back to reference Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14:301–16.CrossRefPubMedPubMedCentral Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14:301–16.CrossRefPubMedPubMedCentral
7.
go back to reference Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Clinicopathological features of gastric carcinoma in younger and middle-aged patients: a comparative study. J Gastrointest Surg. 2006;10:1023–32.CrossRefPubMed Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Clinicopathological features of gastric carcinoma in younger and middle-aged patients: a comparative study. J Gastrointest Surg. 2006;10:1023–32.CrossRefPubMed
8.
go back to reference Llanos O, Butte JM, Crovari F, Duarte I, Guzman S. Survival of young patients after gastrectomy for gastric cancer. World J Surg. 2006;30:17–20.CrossRefPubMed Llanos O, Butte JM, Crovari F, Duarte I, Guzman S. Survival of young patients after gastrectomy for gastric cancer. World J Surg. 2006;30:17–20.CrossRefPubMed
9.
go back to reference Kong X, Wang JL, Chen HM, Fang JY. Comparison of the clinicopathological characteristics of young and elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol. 2012;106:346–52.CrossRefPubMed Kong X, Wang JL, Chen HM, Fang JY. Comparison of the clinicopathological characteristics of young and elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol. 2012;106:346–52.CrossRefPubMed
10.
go back to reference Park HJ, Ahn JY, Jung HY, Lim H, Lee JH, Choi KS, et al. Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years. Gastric Cancer. 2014;17:649–60.CrossRefPubMed Park HJ, Ahn JY, Jung HY, Lim H, Lee JH, Choi KS, et al. Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years. Gastric Cancer. 2014;17:649–60.CrossRefPubMed
11.
go back to reference Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg. 2007;94:737–42.CrossRefPubMed Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg. 2007;94:737–42.CrossRefPubMed
12.
go back to reference Pisanu A, Podda M, Cois A, Uccheddu A. Gastric cancer in the young: is it a different clinical entity? A retrospective cohort study. Gastroenterol Res Pr. 2014;2014:125038. Pisanu A, Podda M, Cois A, Uccheddu A. Gastric cancer in the young: is it a different clinical entity? A retrospective cohort study. Gastroenterol Res Pr. 2014;2014:125038.
13.
14.
go back to reference Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Jedrys J, Szczepanik AM, et al. Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbeck’s Arch Surgery/Deutsche Gesellschaft fur Chirurgie. 2008;393:37–43.CrossRef Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Jedrys J, Szczepanik AM, et al. Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbeck’s Arch Surgery/Deutsche Gesellschaft fur Chirurgie. 2008;393:37–43.CrossRef
15.
go back to reference Schildberg CW, Croner R, Schellerer V, Haupt W, Schildberg FW, Schildberg M, et al. Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patients. Adv Med Sci. 2012;57:259–65.CrossRefPubMed Schildberg CW, Croner R, Schellerer V, Haupt W, Schildberg FW, Schildberg M, et al. Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patients. Adv Med Sci. 2012;57:259–65.CrossRefPubMed
16.
go back to reference Kubota T, Hiki N, Sano T, Nomura S, Nunobe S, Kumagai K, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21:891–8.CrossRefPubMed Kubota T, Hiki N, Sano T, Nomura S, Nunobe S, Kumagai K, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21:891–8.CrossRefPubMed
17.
go back to reference Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.CrossRefPubMed Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.CrossRefPubMed
18.
go back to reference Velanovich V, Wollner I, Ajlouni M. Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies. J Gastrointest Surg. 2000;4:542–6.CrossRefPubMed Velanovich V, Wollner I, Ajlouni M. Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies. J Gastrointest Surg. 2000;4:542–6.CrossRefPubMed
19.
go back to reference Yamagata Y, Amikura K, Kawashima Y, Yatsuoka T, Nishimura Y, Sakamoto H, et al. Staging laparoscopy in advanced gastric cancer: usefulness and issues requiring improvement. Hepatogastroenterology. 2013;60:751–5.PubMed Yamagata Y, Amikura K, Kawashima Y, Yatsuoka T, Nishimura Y, Sakamoto H, et al. Staging laparoscopy in advanced gastric cancer: usefulness and issues requiring improvement. Hepatogastroenterology. 2013;60:751–5.PubMed
20.
go back to reference Kapiev A, Rabin I, Lavy R, Chikman B, Shapira Z, Kais H, et al. The role of diagnostic laparoscopy in the management of patients with gastric cancer. Isr Med Assoc Journal IMAJ. 2010;12:726–8.PubMed Kapiev A, Rabin I, Lavy R, Chikman B, Shapira Z, Kais H, et al. The role of diagnostic laparoscopy in the management of patients with gastric cancer. Isr Med Assoc Journal IMAJ. 2010;12:726–8.PubMed
21.
go back to reference Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36:873–80.PubMedPubMedCentral Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36:873–80.PubMedPubMedCentral
22.
go back to reference Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004;203:681–7.CrossRefPubMed Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004;203:681–7.CrossRefPubMed
23.
go back to reference Huntsman DG, Carneiro F, Lewis FR, Macleod PM, Hayashi A, Monaghan KG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001;344:1904–9.CrossRefPubMed Huntsman DG, Carneiro F, Lewis FR, Macleod PM, Hayashi A, Monaghan KG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001;344:1904–9.CrossRefPubMed
Metadata
Title
Clinicopathological features of gastric cancer in young patients
Authors
Yukiko Takatsu
Naoki Hiki
Souya Nunobe
Manabu Ohashi
Michitaka Honda
Toshiharu Yamaguchi
Toshifusa Nakajima
Takeshi Sano
Publication date
01-04-2016
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2016
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0484-1

Other articles of this Issue 2/2016

Gastric Cancer 2/2016 Go to the issue